163 related articles for article (PubMed ID: 21481261)
21. Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma.
Shimada H; Takeda A; Nabeya Y; Okazumi SI; Matsubara H; Funami Y; Hayashi H; Gunji Y; Kobayashi S; Suzuki T; Ochiai T
Cancer; 2001 Aug; 92(3):663-9. PubMed ID: 11505413
[TBL] [Abstract][Full Text] [Related]
22. Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.
Savinainen KJ; Saramäki OR; Linja MJ; Bratt O; Tammela TL; Isola JJ; Visakorpi T
Am J Pathol; 2002 Jan; 160(1):339-45. PubMed ID: 11786427
[TBL] [Abstract][Full Text] [Related]
23. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
Cui Y; Xue Y; Dong S; Zhang P
J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
[TBL] [Abstract][Full Text] [Related]
24. MET and PTEN gene copy numbers and Ki-67 protein expression associate with pathologic complete response in ERBB2-positive breast carcinoma patients treated with neoadjuvant trastuzumab-based therapy.
Calhoun BC; Portier B; Wang Z; Minca EC; Budd GT; Lanigan C; Tubbs RR; Morrison LE
BMC Cancer; 2016 Aug; 16(1):695. PubMed ID: 27576528
[TBL] [Abstract][Full Text] [Related]
25. BRCA1 mRNA expression as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma treated with cisplatin- or docetaxel-based chemotherapy/chemoradiotherapy.
Gao Y; Zhu J; Zhang X; Wu Q; Jiang S; Liu Y; Hu Z; Liu B; Chen X
PLoS One; 2013; 8(1):e52589. PubMed ID: 23326344
[TBL] [Abstract][Full Text] [Related]
26. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
[TBL] [Abstract][Full Text] [Related]
27. ErbB2 copy number gain is associated with adverse outcome in canine mammary carcinoma.
Sakai K; Chambers JK; Uchida K; Nakagawa T; Nishimura R; Yonezawa T; Maeda S
J Vet Med Sci; 2021 Mar; 83(3):370-377. PubMed ID: 33473058
[TBL] [Abstract][Full Text] [Related]
28. Relative quantification of ERBB2 mRNA in invasive duct carcinoma of the breast: correlation with ERBB-2 protein expression and ERBB2 gene copy number.
Mrhalová M; Kodet R; Kalinová M; Hilská I
Pathol Res Pract; 2003; 199(7):453-61. PubMed ID: 14521261
[TBL] [Abstract][Full Text] [Related]
29. Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis.
Loges S; Clausen H; Reichelt U; Bubenheim M; Erbersdobler A; Schurr P; Yekebas E; Schuch G; Izbicki J; Pantel K; Bokemeyer C; Fiedler W
Clin Cancer Res; 2007 Jan; 13(1):76-80. PubMed ID: 17200341
[TBL] [Abstract][Full Text] [Related]
30. Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma.
Adams L; Roth MJ; Abnet CC; Dawsey SP; Qiao YL; Wang GQ; Wei WQ; Lu N; Dawsey SM; Woodson K
Cancer Prev Res (Phila); 2008 Oct; 1(5):357-61. PubMed ID: 19137073
[TBL] [Abstract][Full Text] [Related]
31. The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
Chen YH; Lu HI; Lo CM; Wang YM; Chou SY; Hsiao CC; Huang CC; Shih LH; Chen SW; Li SH
BMC Cancer; 2018 Aug; 18(1):837. PubMed ID: 30126380
[TBL] [Abstract][Full Text] [Related]
32. Integrative analysis of copy number and transcriptional expression profiles in esophageal cancer to identify a novel driver gene for therapy.
Dong G; Mao Q; Yu D; Zhang Y; Qiu M; Dong G; Chen Q; Xia W; Wang J; Xu L; Jiang F
Sci Rep; 2017 Feb; 7():42060. PubMed ID: 28169357
[TBL] [Abstract][Full Text] [Related]
33. Circulating miR-155 expression in plasma: a potential biomarker for early diagnosis of esophageal cancer in humans.
Liu R; Liao J; Yang M; Shi Y; Peng Y; Wang Y; Pan E; Guo W; Pu Y; Yin L
J Toxicol Environ Health A; 2012; 75(18):1154-62. PubMed ID: 22891887
[TBL] [Abstract][Full Text] [Related]
34. ERBB2 amplifications in esophageal adenocarcinoma.
Dahlberg PS; Jacobson BA; Dahal G; Fink JM; Kratzke RA; Maddaus MA; Ferrin LJ
Ann Thorac Surg; 2004 Nov; 78(5):1790-800. PubMed ID: 15511476
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
[TBL] [Abstract][Full Text] [Related]
36. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K
Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701
[TBL] [Abstract][Full Text] [Related]
37. Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinoma.
Li J; Li M; Gao F; Ge X
Cancer Biomark; 2017; 18(1):11-17. PubMed ID: 27802201
[TBL] [Abstract][Full Text] [Related]
38. Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression.
Xie Z; Li T; Huang B; Liu S; Zhang L; Zhang Q
Technol Cancer Res Treat; 2020; 19():1533033820928117. PubMed ID: 32441221
[TBL] [Abstract][Full Text] [Related]
39. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
[TBL] [Abstract][Full Text] [Related]
40. Expression of Stathmin and vascular endothelial growth factor C in esophageal cancer and their combined diagnostic value.
Luo X; Dai Y; Cao Y
J BUON; 2019; 24(6):2523-2530. PubMed ID: 31983128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
